Skip to content

Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer

Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07361458
Enrollment
9
Registered
2026-01-23
Start date
2024-12-01
Completion date
2025-11-20
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

oncology, model, health economics, open source model, open source, prototype, wireframes

Brief summary

The investigators intend to create and test an interactive prototype of an online health economic model platform, ModEx™ (renamed HModEx®), to house oncology models. The primary objective is to create the HModEx® health economic model platform. The secondary objective is to conduct usability testing of search, quality and collaboration on the HModEx® prototype for 20 oncology health economic models with expert advisory panel participants.

Detailed description

Primary Endpoint: Iteratively unit test 4 tasks (A) Revise model platform and back end, (B) Refine the model taxonomy/characterization (i.e., ontology) and search module, (C) Revamp submission module, and (D) Implement paid modules) individually to ascertain 100% pass of common functionality (e.g., searching, uploading, and evaluating models) in the system back end and then iteratively perform integration testing via the front-end user interface until 100% pass using the System Usability Scale (as below). The System Usability Scale yields a single number representing a composite measure of the overall usability of the system being studied. To calculate the System Usability Scale score, first sum the score contributions from each item. Each item's score contribution will range from 0 to 4. For items 1,3,5,7, and 9 the score contribution is the scale position minus 1. For items 2,4,6,8 and 10, the contribution is 5 minus the scale position. Multiply the sum of the scores by 2.5 to obtain the overall value of System Usability Score; scores range from 0 to 100, with higher numbers being better. Secondary Endpoints: Measure the success of Aim 2 by (1) completion of 80% of tasks in usability testing with scores of ≥68 on the System Usability Scale, a validated questionnaire, and (2) satisfaction with the site. Testing will focus on user interaction with the system, emphasizing effectiveness, efficiency, engagingness, error tolerance, and ease of learning. Specifically, the investigators will assess the ability of the project team and Advisory Panel member participants to log into the platform, configure and manage their modeling projects, and annotate or categorize them in accordance with an ontological index. The investigators will assign participants to interact with at least 2 randomly selected models and associated data files, iterating on this milestone until the investigators achieve 100% success.

Interventions

OTHERopen source health economic models

open source health economic models

Sponsors

Arnold Consultancy & Technology, LLC
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Advisory Panelist participants will be randomly assigned to interact with wireframes of the prototype and then several models according to key use cases (e.g. model publishing, model searching, user registration, user profile updating, payments, etc.), and then provide answers to the System Usability Scale questions.

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Expert Advisory Panel member

Exclusion criteria

* Non-English-speaker

Design outcomes

Primary

MeasureTime frameDescription
Alpha testing of wireframe usability2 monthsIteratively unit test 4 tasks (A) Revise model platform and back end, (B) Refine the model taxonomy/characterization (i.e., ontology) and search module, (C) Revamp submission module, and (D) Implement paid modules) individually to ascertain 100% pass of common functionality (e.g., searching, uploading, and evaluating models) in the system back end and then iteratively perform integration testing via the front-end user interface until 100% pass using the System Usability Scale. The overall value of the System Usability Score ranges from 0 to 100. The higher the score on the System Usability Scale, the better.

Secondary

MeasureTime frameDescription
Beta testing of prototype usability4 monthsMeasure the success of Aim 2 by (1) completion of 80% of tasks in usability testing with scores of ≥68 on the System Usability Scale, a validated questionnaire, and (2) satisfaction with the site. Testing will focus on user interaction with the system, emphasizing effectiveness, efficiency, engagingness, error tolerance, and ease of learning. Specifically, the investigators will assess the ability of the project team and Advisory Panel member participants to log into the platform, configure and manage their modeling projects, and annotate or categorize them in accordance with an ontological index. The investigators will assign panelist participants to interact with at least 2 randomly selected models and associated data files, iterating on this milestone until the investigators achieve 100% success. The overall value of the System Usability Score ranges from 0 to 100. The higher the score on the System Usability Scale, the better.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRenee JG Arnold, PharmD

Arnold Consultancy & Technology, LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026